-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
"China Stroke Statistics 2019: A From Report on National Center for Healthcare Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, The Chinese Stroke Association, National for Center Chronic and Non-Communicable Disease Control and China Center for Disease. Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations, led by Professors Zhao Jizong and Wang Congjun of Beijing Tiantan Hospital affiliated with Capital Medical University, the United Nations Center for Medical Quality Control of Nervous System Diseases, the National Center for Clinical Medicine for Neurological Diseases, the Chinese Stroke Society, the Chinese Center for Disease Control and Prevention's Center for Chronic Noncommunicable Diseases Prevention and Control, the Global Neuroscience and Stroke Synergy.
the Chinese People's Bank of China release the China Stroke Report 2019? In recent years, stroke has become one of the leading causes of death among the residents of our country.
the Global Working Group on the Burden of Disease estimates the lifetime risk of stroke: 24.9 per cent globally, 39.3 per cent in China, which has become the country with the highest lifetime risk of stroke and the highest burden of disease.
To further give the world a more intuitive understanding of the current situation of stroke in China, the National Center for Medical Quality Control of Neurological Diseases, under the guidance of the National Health Council's Medical and Medical Administration, co-authored the China Stroke Report 2019, published in the English-language journal SVN.
The report aims to describe the epidemiological status and risk factors of stroke in urban and rural residents in China, the incidence of stroke patients, clinical characteristics, diagnosis and treatment processes and hospital outcomes and other disease occurrence and quality of medical care indicators, will better prevent disease occurrence, rapid and efficient diagnosis and treatment, improve the quality of medical care, optimize the allocation of resources and formulate relevant health and research policies to provide scientific data and information support.
The data used in this report are derived from more than a dozen industry and national databases, including registered studies such as stroke surveillance, epidemiological investigation, national stroke registration (see table below), and administrative databases such as the National Hospital Quality Monitoring System (HQMS) of the National Health And Health Commission, which can more fully reflect the current situation of stroke prevention and diagnosis in China.
This report is the first statistical report in China in recent years that more comprehensively reflects the current situation of stroke epidemic in China, the level of medical quality during hospitalization and the outcome of hospitalization, with a view to providing Chinese experience for the prevention and treatment of stroke worldwide.
The main content of China Stroke Report 2019 is stroke epidemiological data1. In 2018, at least one in every 5 deaths in China died of stroke, and the mortality rate of cerebrovascular disease among Chinese residents was 149.49 per 100,000, accounting for 22% of the total mortality rate of Chinese residents.
the mortality rate is higher than that of men and higher than that of women in rural areas.
, the incidence and prevalence of stroke among rural residents are significantly higher than among urban residents.
stroke has become the leading cause of premature death and the burden of disease.
2005-2018, the overall mortality rate of cerebrovascular disease in China showed a slow upward trend.
the main reason for the rising mortality rate of cerebrovascular disease is the aging of the population.
years, the crude mortality rate of cerebrovascular disease in rural areas has been higher than in urban areas.
, the incidence and prevalence of cerebrovascular diseases in rural areas are significantly higher than in urban areas.
risk factors for stroke Hypertension and smoking are the primary risk factors in stroke prevention and management.
The most common risk factors for stroke survivors were hypertension (63.0%-84.2%) and smoking (31.7%-47.6%), followed by abnormal blood lipids and diabetes, with a relatively low rate of atrial fibrillation (2.7%-7.4%).
these risk factors also show high prevalence levels throughout the population.
according to the epidemiological survey data of relevant diseases in China, the smoking rate of 15 years and older in China is 26.6%, and the prevalence rate of hypertension among people aged 18 and over is 25.2%.
suggest that hypertension is still a top priority in stroke prevention and treatment.
stroke inpatients HQMS in 2018 included 3.01 million stroke inpatients, ischemic stroke accounted for about 82%, age 66 years old, hemorrhagic stroke patients are younger;
more than half of hemorrhagic stroke patients were admitted to the hospital through emergency care; ischemic stroke patients were admitted more on weekdays and more on Mondays.
this suggests that china's current cerebrovascular disease emergency system is under-used, ischemic stroke patients in the hospital in the wrong transport and delay and so on there are still a lot of problems.
In the type of medical insurance coverage for stroke inpatients, the cumulative coverage of urban residents, urban workers and new farmers was more than 75% (35.3% for urban residents, 23.2% for urban workers, 16.3% for new rural cooperative medical care), and the out-of-payment ratio was about 10% (including some patients who visited the hospital);
analysis of data based on the medical quality management system shows that the proportion of hemorrhagic stroke is higher among stroke patients at high altitudes, such as 61% in Tibet Autonomous Region, 44% in Qinghai Province and 35% in Guizhou Province. The first analysis of the age distribution of hospitalizations for stroke in
reported that children's stroke, cerebral infarction, cerebral hemorrhage and subcampic hemorrhage of the cobwebs, accounted for 0.1%, 0.6% and 1.4%, respectively.
hospitalizations for stroke are concentrated in the age of 50 and above, the proportion of men is higher before the age of 65, and the proportion of women is higher after the age of 65.
risk factor for people hospitalized for stroke is hypertension is the primary risk factor for stroke patients, and pneumonia/lung infection is the primary complication.
, the proportion of cerebral infarction patients with combined pneumonia/lung infection was 10.1%, the proportion of cerebral hemorrhage patients was 31.4%, and the cobweb hemorrhage patients were 25.2%.
the proportion of hospital deaths/non-medically ordered hospitalizations of patients with stroke inpatients was 8.3%, of which the proportion of hospital deaths/non-hospitalizations of patients with cerebral infarction was 5.8% and that of patients with cerebral hemorrhage was 19.3% 5%, cobweb hemorrhage patients were 19.4%, the median length of hospital stay was 10 days, of which cerebral infarction patients were 10 days, cerebral hemorrhage patients were 14 days, cobweb hemorrhage patients were 12 days.
stroke patients followed the guidelines of intervention indicators of cerebral infarction, cerebral hemorrhage, cobweb hemorrhage in hospital patients followed the guidelines of the comprehensive implementation rate of the indicators followed the guidelines for treatment, respectively, 0.77 to 0.21, 0.72 to 0.28 and 0.59 to 0.32.
Among them, the proportion of ischemic stroke patients who arrived at the hospital within 3.5 hours and had no lysolytic contraindication was 24%;
Finally, President Wang also shared some research on the "Golden Bridge" system, a technical system for improving the quality of medical care for cerebrovascular diseases in China, and summarized the key points in the prevention and treatment of cerebrovascular diseases: (1) reference to clinical studies to provide more evidence;
.